37
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Tribological, Biomedical Studies of 4 Bromo–4' Chloro Benzylidene Aniline Macro-crystals for Photonic, Mechano, Electronic-displays and Pharma Applications

, , & ORCID Icon
Pages 1850-1879 | Received 14 Dec 2022, Accepted 24 Apr 2023, Published online: 15 May 2023
 

Abstract

The crystal of 4 Bromo − 4' Chloro Benzylidene Aniline-BCBA is synthesized and crystallized in the orthorhombic with Pccn space group. The lattice constants are a = 24.995 Å, b = 6.286 Å, c = 7.326 Å. The bond parameters are reported with statistics for the comparison purpose. The computational structural analyses about Vander Waal’s, 3D representation are portrayed; Raman spectroscopy provides the functional groups of BCBA. Mass spectrometer data reveal the molecular mass of BCBA as 295.5797; the Vander Waal’s type of interactions presented in the title compound, a systematic study of Super-cell, Laue’s model and Clinographic view of BCBA and device displays are carried out computationally. Hirshfeld surface analysis is used to envisage the many intermolecular interactions for the configuration of supramolecular structural design of BCBA. Dielectric properties are studied in the ambience of the room temperature for identifying the existence of all polarizations and in bio-medicinal use too as a better agent against diabetic macro level as IC50 of 48.76 and 52.12 for alpha-amylase and alpha-glucosidase as in-vitro case; the wear and tear of BCBA-macro is better scaled up for tribological study with frictional coefficient as 3*10−3.

Acknowledgments

The authors would like to thank the IITM for XRD data and spectral data.

Author contributions

HG: conducted the research work and designed the experiment and corrected the manuscript; KSR: designed the study and visualization; MV: performed the optical studies and diagram corrections and clarity; KSK: grown the crystal, supervised the research work for structural case and over all write up; Also, all authors reviewed the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

All the data is utilized and submitted in paper and no separate repository.

Additional information

Funding

No fund from any source and authors spent own funding.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.